Princeton-based Sun Pharmaceutical Industries Limited announced the appointment of Jeremy Allen as vice president, corporate ...

TORONTO, Oct. 23, 2025 /CNW/ – (“Apotex” or the “Company”), the largest Canadian-based pharmaceutical company, today ...

RAMM Pharma Corp. (including its wholly owned subsidiaries, the 'Company” or 'RAMM') (CSE: RAMM), wishes to notify shareholders that a disruption due to the ongoing Canada Post strike (the 'Postal ...

CALGARY — Federal Health Minister Marjorie Michel is set to meet today in Calgary with her provincial and territorial ...

The Mesalamine suppositories will be manufactured at Zydus Lifesciences’ facility in Changodar, Ahmedabad, Gujarat. Shares of ...

Cipher Pharmaceuticals shares advanced Tuesday after the company said it was awarded 4.2 million Canadian dollars ($3 million) and royalties from its arbitration with Pharmaceuticals Industries.

Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global Canada pharmaceutical packaging market hit USD 7.53 billion in 2025, with current forecasts pointing to USD 14.43 billion by 2034, according to ...

U.S. President Donald Trump said Thursday that he will put import taxes on pharmaceutical drugs, kitchen cabinets and ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for generic Mesalamine ...

The pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan.

Cipher’s flagship product, Epuris, continues to dominate Canada’s isotretinoin market with a 51.3% market share and ...